Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Chinese Patent Office
Fish and Richardson
Merck
Johnson and Johnson
McKesson
Teva
US Department of Justice
Federal Trade Commission

Generated: July 18, 2018

DrugPatentWatch Database Preview

CEFUROXIME SODIUM IN PLASTIC CONTAINER Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Cefuroxime Sodium In Plastic Container, and when can generic versions of Cefuroxime Sodium In Plastic Container launch?

Cefuroxime Sodium In Plastic Container is a drug marketed by Samson Medcl and is included in one NDA.

The generic ingredient in CEFUROXIME SODIUM IN PLASTIC CONTAINER is cefuroxime sodium. There are sixty-one drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cefuroxime sodium profile page.
Summary for CEFUROXIME SODIUM IN PLASTIC CONTAINER
Drug patent expirations by year for CEFUROXIME SODIUM IN PLASTIC CONTAINER

US Patents and Regulatory Information for CEFUROXIME SODIUM IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Samson Medcl CEFUROXIME SODIUM IN PLASTIC CONTAINER cefuroxime sodium INJECTABLE;INJECTION 065251-001 Dec 30, 2009 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Samson Medcl CEFUROXIME SODIUM IN PLASTIC CONTAINER cefuroxime sodium INJECTABLE;INJECTION 065251-002 Dec 30, 2009 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Cerilliant
Harvard Business School
Daiichi Sankyo
Federal Trade Commission
Teva
Cipla
Cantor Fitzgerald
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.